Screening method for anticancer drug
US8323943B2 · kind B2 · utility
0Cited by
2References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 13, 2008 |
| Grant date | Dec 4, 2012 |
| Priority date | — |
| Expiry date | Jan 2, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/91215
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The screening method for an anticancer drug comprises selecting a compound which blocks the kinase activity of TNIK, or blocks the combination of TNIK with β-catenin/TC4 transcription complex.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.